ICD-10-CM Billable Code

C69.51

Malignant neoplasm of right lacrimal gland and duct

Clinical Classification Guidelines

Medical Intelligence & Overview

Malignant neoplasm of the right lacrimal gland and duct refers to a type of cancer that originates in the tear-producing gland located in the corner of the eye, near the nose. This rare form of cancer affects the tissues responsible for tear secretion, potentially impacting eye function and health. Recognizing this condition early is crucial for managing the disease effectively.

Causes & Symptoms

Clinical Causes: Genetic mutations that cause abnormal cell growth in the lacrimal gland Exposure to certain environmental factors such as radiation or carcinogenic chemicals History of prior eye or head cancers that may spread to the lacrimal gland Chronic inflammation or infections affecting the eye region Age-related cellular changes, as the risk increases with age

Key Symptoms: Persistent swelling or a lump in the corner of the eye near the nose Unexplained eye irritation or discomfort Changes in the appearance of the eye or eyelid Drooping eyelid or protrusion of the eye Visual disturbances, including blurred or double vision Discharge from the affected eye Decreased eye movement or sensation around the eye

Diagnostic & Treatment

Diagnosis Path: A detailed medical history and physical examination of the eye and surrounding tissues Imaging tests such as MRI or CT scans to determine the size, location, and extent of the tumor Biopsy procedures to obtain tissue samples for microscopic analysis Histopathological evaluation to confirm malignancy and define the tumor type Additional tests if necessary to assess whether the cancer has spread (metastasized)

Treatment Protocols: Surgical removal of the tumor, which may involve excision of the affected gland and surrounding tissues Radiation therapy to target residual cancer cells or reduce tumor size before surgery Chemotherapy in cases where the cancer has spread or as an adjunct to other treatments Targeted therapy options, if specific molecular markers are identified in the tumor Regular follow-up and monitoring to detect potential recurrence or complications

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C69.51 a billable ICD-10 code?
Yes, C69.51 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C69.51?
Clinical documentation must specify the nature of Malignant neoplasm of right lacrimal gland and duct and any associated comorbidities for accurate reporting.

Cite this Clinical Reference